UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
115.55
-1.58 (-1.35%)
Sep 2, 2025, 3:58 PM EDT
UCB SA Market Cap
UCB SA has a market cap or net worth of $43.81 billion as of September 2, 2025. Its market cap has increased by 28.69% in one year.
Market Cap
43.81B
Enterprise Value
45.29B
Revenue
8.04B
Ranking
n/a
PE Ratio
28.01
Stock Price
$115.55
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 43.81B, an increase of 3,548.84%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 44.29B | 17.32% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |